Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fhB7H3.CAR-T in Recurrent Malignant Ovarian Cancer
NCT05211557Phase 2Recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Nov 2021
- Primary completion
- Aug 2023
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of fhB7H3.CAR-Ts in ovarian cancer, sponsored by The Affiliated Hospital of Xuzhou Medical University. Started Nov 2021; status: recruiting.
02
Drugs
fhB7H3.CAR-Ts
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05211557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05211557.